Eyenovia (EYEN)
(Delayed Data from NSDQ)
$0.91 USD
+0.04 (4.04%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $0.92 +0.01 (0.71%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Earnings News For EYEN
-
Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol
-
Eyenovia, Inc. (EYEN) Reports Q4 Loss, Misses Revenue Estimates
-
Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
-
Eyenovia Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Eyenovia Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Eyenovia Reports First Quarter 2023 Financial Results and Provides Business Update
-
Eyenovia Reports Fourth Quarter 2022 Financial Results and Provides Business Update
-
Eyenovia Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Eyenovia, Inc. (EYEN) Reports Q3 Loss, Misses Revenue Estimates